Brambilla F, Bellodi L, Perna G, Bertani A, Panerai A, Sacerdote P
Psychoneuroendocrine Center, Ospedale Psichiatrico Pini, Italy.
Psychiatry Res. 1994 Nov;54(2):135-42. doi: 10.1016/0165-1781(94)90002-7.
Plasma interleukin-1 beta (IL-1 beta) concentrations were measured in 10 outpatients with panic disorder before and on days 30 and 32 of treatment with alprazolam (2-2.5 mg/day). IL-1 beta concentrations were found to be significantly higher in patients than in control subjects both before and during therapy. Thus, IL-1 beta levels may be a marker of panic disorder that is not related to the current level of symptomatology.